Stocks Health care SPTX
NASDAQ · Health careSeaport Therapeutics, Inc. (SPTX)
At June 30, 2026 it held $64.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 3, 2026.
What Seaport Therapeutics, Inc. does
Seaport Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SPTX.
Latest SEC filings
What Seaport Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 5, 2026Passive stake (5% or more) SCHEDULE 13G
- August 5, 2026Passive stake (5% or more) SCHEDULE 13G
- August 3, 2026Quarterly report 10-Q · period to June 30, 2026
- August 3, 2026
- June 8, 2026Quarterly report 10-Q · period to March 31, 2026
- June 8, 2026
- May 11, 2026Activist stake (5% or more) SCHEDULE 13D
- May 11, 2026Passive stake (5% or more) SCHEDULE 13G
- May 6, 2026Activist stake (5% or more) SCHEDULE 13D
Questions about SPTX
What does Seaport Therapeutics, Inc. do?
Seaport Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SPTX.
When did Seaport Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 3, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake (5% or more) from August 14, 2026.
Similar companies
Follow SPTX
Get an email when Seaport Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow SPTX: get an email when it filesWhere the numbers come from
Financial figures are the values Seaport Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.